Literature DB >> 19738324

Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury.

M Birdsall Abrams1, Cecilia Dominguez, Karin Pernold, Roxanne Reger, Zsuzsanna Wiesenfeld-Hallin, Lars Olson, Darwin Prockop.   

Abstract

PURPOSE: Previous reports established that after a contusion injury to the rat spinal cord, locomotor function was enhanced by the transplantation of cells from bone marrow referred to as either mesenchymal stem cells or multipotent mesenchymal stromal cells (MSCs). It has also been established that neural stem cells (NSCs) enhance locomotor function after transplantation into the injured rat spinal cord. However, the beneficial effects of NSCs are limited by graft-induced allodynia-like responses. Little is known about the effects of MSCs on sensory function in spinal cord injury. Therefore, the objective of this research was to determine whether transplantation of MSCs into the injured rat spinal cord induces allodynia-like responses.
METHODS: Contusion injuries of two different severities were induced in rats to examine the effects of transplantation with MSCs on sensorimotor deficits. The effects of MSCs on chronic inflammation were investigated, since inflammation is reported to have a role in the sensorimotor deficits associated with spinal cord injury. In addition, observations in other models suggest that MSCs possess immunosuppressive effects.
RESULTS: We found that in contrast to previous observations with the transplantation of neural stem cells, transplantation of MSCs did not induce allodynia. MSCs attenuated injury-induced sensitivity to mechanical stimuli but had no effect on injury-induced sensitivity to cold stimuli. MSCs also significantly attenuated the chronic inflammatory response as assayed by GFAP immunoreactivity for reactive astrocytes and ED1 immunoreactivity for activated macrophages/microglia. In addition, transplantation of MSCs increased white matter volumes and decreased cyst size in sections of the cord containing the lesion.
CONCLUSION: The results suggest that the sensorimotor enhancements produced by MSCs can at least in part be explained by anti-inflammatory/immunosuppressive effects of the cells, similar to such effects of these cells observed in other experimental models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738324     DOI: 10.3233/RNN-2009-0480

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  55 in total

1.  Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain.

Authors:  Wei Guo; Hu Wang; Shiping Zou; Ming Gu; Mineo Watanabe; Feng Wei; Ronald Dubner; George T-J Huang; Ke Ren
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

2.  Transplantation of Human Amniotic Mesenchymal Stem Cells Promotes Functional Recovery in a Rat Model of Traumatic Spinal Cord Injury.

Authors:  Hong-Long Zhou; Xue-Jun Zhang; Mao-Ying Zhang; Zhong-Jie Yan; Zhi-Min Xu; Ru-Xiang Xu
Journal:  Neurochem Res       Date:  2016-06-28       Impact factor: 3.996

3.  Meta-analysis of stem cell transplantation for reflex hypersensitivity after spinal cord injury.

Authors:  Xuemei Chen; Bohan Xue; Yuping Li; Chunhua Song; Peijun Jia; Xiuhua Ren; Weidong Zang; Jian Wang
Journal:  Neuroscience       Date:  2017-06-27       Impact factor: 3.590

Review 4.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

5.  Neural Stem Cell-Conditioned Medium Suppresses Inflammation and Promotes Spinal Cord Injury Recovery.

Authors:  Zhijian Cheng; Dale B Bosco; Li Sun; Xiaoming Chen; Yunsheng Xu; Wenjiao Tai; Ruth Didier; Jinhua Li; Jianqing Fan; Xijing He; Yi Ren
Journal:  Cell Transplant       Date:  2016-10-12       Impact factor: 4.064

6.  Neuroprotection and axonal regeneration after lumbar ventral root avulsion by re-implantation and mesenchymal stem cells transplant combined therapy.

Authors:  Abel Torres-Espín; Dora Luz Corona-Quintanilla; Joaquim Forés; Ilary Allodi; Francisco González; Esther Udina; Xavier Navarro
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes.

Authors:  Abel Torres-Espín; Elena Redondo-Castro; Joaquim Hernandez; Xavier Navarro
Journal:  J Neurotrauma       Date:  2015-01-22       Impact factor: 5.269

8.  Glycogen synthase kinase 3 (GSK3)-inhibitor SB216763 promotes the conversion of human umbilical cord mesenchymal stem cells into neural precursors in adherent culture.

Authors:  Liyang Gao; Mingyan Zhao; Peng Li; Junchao Kong; Zhijun Liu; Yonghua Chen; Rui Huang; Jiaqi Chu; Juanhua Quan; Rong Zeng
Journal:  Hum Cell       Date:  2016-09-07       Impact factor: 4.174

9.  Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

Authors:  Kevin Kemp; Elizabeth Gray; Elizabeth Mallam; Neil Scolding; Alastair Wilkins
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 10.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.